Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 11:09 PM ET


Company Overview of Grifols Therapeutics, Inc.

Executive Profile

Thomas J. Lynch Jr., J.D., M.D., Ph.D.

Senior Vice President of Corporate Compliance & Regulatory Affairs, Grifols Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.



Dr. Thomas J. Lynch, also known as Tom, Jr., J.D., M.D., Ph.D. served as Senior Vice President of Corporate Compliance Regulatory & Public Policy of Talecris Biotherapeutics Holdings Corp., and its subsidiary Talecris Biotherapeutics, Inc. since 2006. Dr. Lynch served as Vice President, Corporate Governance and Compliance of Talecris BioTherapeutics Inc. since April 2005 and Talecris Biotherapeutics Holdings Corporation. From August 19, 2003 to 2005, Dr. Lynch served ...

Corporate Headquarters

79 T.W. Alexander Drive
Research Triangle Park, North Carolina 27709

United States

Phone: 919-316-6300
Fax: 919-316-6316

Board Members Memberships

There is no Board Members Memberships data available.


Georgetown University
Master's Degree
Clark University
Yale University
Wayne State University
American International College Inc

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Grifols Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at